Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a Locations section listing North Carolina as the study site; removed the previous North Carolina Locations entry and updated the footer to reflect the change.
    Difference
    0.2%
    Check dated 2025-12-19T19:13:28.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-28T05:47:58.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-21T02:00:46.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The government funding/operating status banner has been removed from the page, removing ancillary status notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-13T22:34:34.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Results have been posted and the study status shows Completed, with enrollment and completion dates updated accordingly.
    Difference
    0.4%
    Check dated 2025-10-30T13:09:15.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Major update: adds a government-status notice and the new software version v3.2.0, replaces the old v3.0.2.
    Difference
    3%
    Check dated 2025-10-02T01:28:49.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.